九典制药
(300705)
| 流通市值：71.13亿 | | | 总市值：117.70亿 |
| 流通股本：2.09亿 | | | 总股本：3.45亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 524,449,305.84 | 425,048,395.14 | 784,164,729.18 | 303,148,051.24 |
| 衍生金融资产 | 0 | 0 | 0 | - |
| 应收票据及应收账款 | 465,770,935.3 | 577,841,998.8 | 495,370,430.54 | 500,336,741.41 |
| 其中：应收票据 | 32,998,055.89 | 32,273,011.48 | 16,191,463.92 | 15,501,595.47 |
| 应收账款 | 432,772,879.41 | 545,568,987.32 | 479,178,966.62 | 484,835,145.94 |
| 应收款项融资 | 31,193,615.47 | 47,918,612.36 | 15,262,210.67 | 17,219,258.01 |
| 预付款项 | 15,673,161.48 | 13,000,066.96 | 14,578,252.76 | 10,921,511.15 |
| 其他应收款合计 | 5,207,443.44 | 3,718,646.05 | 3,962,147.91 | 3,191,060.36 |
| 其中:应收利息 | 0 | 0 | 0 | - |
| 应收股利 | 0 | 0 | 0 | - |
| 存货 | 304,720,472.89 | 265,529,133.3 | 278,314,115.01 | 285,686,168.06 |
| 合同资产 | 0 | 0 | 0 | - |
| 一年内到期的非流动资产 | 0 | 0 | 0 | - |
| 其他流动资产 | 5,650,443.3 | 6,610,093.87 | 4,303,807.79 | 3,354,694.98 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,483,571,928.4 | 1,429,958,213.6 | 1,686,691,228.11 | 1,214,162,005.76 |
| 非流动资产: | | | | |
| 债权投资 | 0 | 0 | 0 | - |
| 其他债权投资 | 0 | 0 | 0 | - |
| 长期应收款 | 0 | 0 | 0 | - |
| 长期股权投资 | 0 | 0 | 0 | - |
| 其他权益工具投资 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 |
| 其他非流动金融资产 | 0 | 0 | 0 | - |
| 投资性房地产 | 3,701,558.59 | 3,775,016.56 | 3,848,474.41 | 3,921,932.5 |
| 固定资产 | 1,079,246,180.49 | 1,071,497,306.31 | 961,434,421.72 | 714,184,656.82 |
| 在建工程 | 81,987,397.67 | 69,315,025.87 | 106,927,969.02 | 298,845,726.23 |
| 生产性生物资产 | 0 | 0 | 0 | - |
| 油气资产 | 0 | 0 | 0 | - |
| 使用权资产 | 128,805.47 | 154,566.56 | 180,327.65 | 206,088.74 |
| 无形资产 | 88,282,266.08 | 88,819,724.21 | 88,304,201.32 | 89,067,138.99 |
| 开发支出 | 24,822,254.94 | 23,412,547.28 | 18,829,141.97 | 12,526,847.73 |
| 商誉 | 0 | 0 | 0 | - |
| 长期待摊费用 | 4,500,437.03 | 4,279,595.72 | 3,658,719.97 | 1,648,503.69 |
| 递延所得税资产 | 59,617,537.67 | 66,294,812.67 | 42,749,736.57 | 46,415,536.37 |
| 其他非流动资产 | 102,418,792.1 | 83,693,001.11 | 56,502,861.04 | 62,011,917.92 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,474,705,230.04 | 1,441,241,596.29 | 1,312,435,853.67 | 1,258,828,348.99 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,958,277,158.44 | 2,871,199,809.89 | 2,999,127,081.78 | 2,472,990,354.75 |
| 流动负债: | | | | |
| 短期借款 | 42,046,184.72 | 51,847,264.16 | 65,868,836.11 | 72,876,586.12 |
| 交易性金融负债 | 0 | 0 | 0 | - |
| 衍生金融负债 | 0 | 0 | 0 | - |
| 应付票据及应付账款 | 122,721,492.38 | 159,294,977.79 | 139,064,194.83 | 140,969,497.19 |
| 其中：应付票据 | 0 | 23,619,014.28 | 37,555,232.42 | 16,893,375.71 |
| 应付账款 | 122,721,492.38 | 135,675,963.51 | 101,508,962.41 | 124,076,121.48 |
| 预收款项 | 0 | 0 | 0 | - |
| 合同负债 | 46,144,813.62 | 37,270,385.51 | 37,486,251.8 | 43,136,585.45 |
| 应付职工薪酬 | 28,992,381.02 | 46,607,359.64 | 26,258,631.93 | 25,977,235.75 |
| 应交税费 | 17,815,660.06 | 36,268,736.56 | 48,059,227.84 | 38,783,573.74 |
| 其他应付款合计 | 64,424,004.36 | 59,629,963.86 | 66,063,507.16 | 51,592,930.44 |
| 其中:应付利息 | 0 | 0 | 0 | - |
| 应付股利 | 0 | 0 | 0 | - |
| 一年内到期的非流动负债 | 6,502,869.58 | 6,063,751.52 | 13,163,720.25 | 9,053,778.8 |
| 其他流动负债 | 28,670,295.77 | 18,579,140.92 | 13,536,128.58 | 14,293,798.2 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 357,317,701.51 | 415,561,579.96 | 409,500,498.5 | 396,683,985.69 |
| 非流动负债: | | | | |
| 长期借款 | 66,451,952.4 | 58,830,636.97 | 285,023,867.52 | 275,264,905.65 |
| 应付债券 | 278,056,750.25 | 273,650,941.97 | 269,194,640.06 | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 租赁负债 | 21,014.73 | 46,759.89 | 72,505.04 | 98,250.2 |
| 长期应付款 | 0 | 0 | 0 | - |
| 长期应付职工薪酬 | 0 | 0 | 0 | - |
| 预计负债 | 0 | 0 | 0 | - |
| 递延收益 | 145,269,051 | 145,374,403.2 | 123,847,331.35 | 95,815,791.6 |
| 递延所得税负债 | 4,338,612.18 | 4,465,588.36 | 4,565,736.21 | 4,691,261.26 |
| 其他非流动负债 | 0 | 0 | 0 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 494,137,380.56 | 482,368,330.39 | 682,704,080.18 | 375,870,208.71 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 851,455,082.07 | 897,929,910.35 | 1,092,204,578.68 | 772,554,194.4 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 345,148,416 | 345,145,427 | 345,145,427 | 344,452,427 |
| 其他权益工具 | 84,926,235.46 | 84,941,690.13 | 84,941,690.13 | - |
| 资本公积 | 537,893,809.06 | 529,901,790.25 | 521,544,148.62 | 512,901,379.23 |
| 减:库存股 | 0 | 0 | 0 | - |
| 其他综合收益 | 0 | 0 | 0 | - |
| 专项储备 | 1,039,190.13 | 1,136,039.56 | 1,416,639.37 | 1,569,998.21 |
| 盈余公积 | 124,462,975.51 | 124,462,975.51 | 91,547,493.81 | 91,547,493.81 |
| 未分配利润 | 1,013,351,450.21 | 887,681,977.09 | 862,327,104.17 | 749,964,862.1 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,106,822,076.37 | 1,973,269,899.54 | 1,906,922,503.1 | 1,700,436,160.35 |
| 少数股东权益 | 0 | 0 | 0 | - |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,106,822,076.37 | 1,973,269,899.54 | 1,906,922,503.1 | 1,700,436,160.35 |
| 负债和股东权益合计 | 2,958,277,158.44 | 2,871,199,809.89 | 2,999,127,081.78 | 2,472,990,354.75 |
| 公告日期 | 2024-04-25 | 2024-04-25 | 2023-10-24 | 2023-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |